Understanding how natural rewards are influenced by brain opioid activity
Isolating the role of endogenous mu-opioid activity in the VTA during natural reward
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF WASHINGTON · NIH-10888174
This study is looking at how certain brain cells that respond to natural rewards might be affected by opioids, which could help us understand why some people struggle with opioid use, especially during tough times like the COVID-19 pandemic.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-10888174 on ClinicalTrials.gov |
What this research studies
This research investigates the role of endogenous mu-opioid activity in the Ventral Tegmental Area (VTA) of the brain and its impact on natural reward-seeking behaviors. By examining how specific neurons in the VTA interact with opioid receptors, the study aims to uncover the neuropharmacological mechanisms that contribute to opioid use disorder. The approach involves advanced techniques to observe neuronal activity and signaling pathways, providing insights into how these processes affect motivation and reward. This research is particularly relevant in the context of rising opioid use and overdose rates during the COVID-19 pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with opioid use disorder or those interested in understanding the neurobiological factors influencing addiction.
Not a fit: Patients who do not have a history of opioid use or are not affected by addiction-related issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating opioid use disorder and improving addiction recovery.
How similar studies have performed: Previous research has shown promising results in understanding the neurobiology of addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ZAMORANO, CATALINA ALEJANDRA — UNIVERSITY OF WASHINGTON
- Study coordinator: ZAMORANO, CATALINA ALEJANDRA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.